Yu U Jiang from 10 Morning Glory Ln, Edison, NJ 08820, age 57, Phone: (908)8229261

Us Patents

Geranylgeranyl Diphosphate Synthase Proteins, Nucleic Acid Molecules And Uses Thereof
view source
US Patent:

59121548, Jun 15, 1999
Filed:

Dec 6, 1996
Appl. No.:

8/761344
Inventors:

Yu Jiang - Princeton NJ
Assignee:

Yale University - New Haven CT
International Classification:

C12N 910
C12N 1554
C12N 1570
C12N 1581
US Classification:

435193
Abstract:

The present invention relates to yeast geranylgeranyl diphosphate synthase proteins and nucleic acid molecules encoding such proteins. Also included are methods to produce geranylgeranyl diphosphate and farnesyl diphosphate.

Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists
view source
US Patent:

20200347020, Nov 5, 2020
Filed:

Jul 22, 2020
Appl. No.:

16/935565
Inventors:

- Rahway NJ, US
Jason M. Cox - East Windsor NJ, US
John S. Debenham - Scotch Plains NJ, US
Scott Edmondson - Clark NJ, US
Eric J. Gilbert - Scotch Plains NJ, US
Yan Guo - Westfield NJ, US
Yu Jiang - East Windsor NJ, US
Hubert Josien - Jersey City NJ, US
Hyunjin M. Kim - Livingston NJ, US
Ping Lan - Plainsboro NJ, US
Shouwu Miao - Edison NJ, US
Christopher W. Plummer - Hoboken NJ, US
Murali Rajagopalan - Edison NJ, US
Unmesh Shah - Neshanic Station NJ, US
Zhongxiang Sun - Princeton NJ, US
Quang T. Truong - Morganville NJ, US
Feroze Ujjainwalla - Hoboken NJ, US
Francisco Velazquez - Clinton NJ, US
Srikanth Venkatraman - Edison NJ, US
Takao Suzuki - Shanghai, CN
Nengxue Wang - Shanghai, CN
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

C07D 217/04
C07D 401/04
C07D 401/12
C07D 413/04
C07D 417/12
C07D 417/14
C07D 401/06
C07D 417/04
A61K 31/4725
C07D 417/06
C07D 217/22
A61K 45/06
A61K 31/472
A61K 9/48
A61P 3/04
A61P 3/06
A61P 3/10
A61P 29/00
Abstract:

The present invention relates to a compound represented by formula (I):and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, NASH, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.

Benzamides-Containing Compounds And Their Use In The Treatment Of Depression
view source
US Patent:

20200054630, Feb 20, 2020
Filed:

Feb 25, 2019
Appl. No.:

16/283929
Inventors:

- Kingston RI, US
Lars Kyhn Rasmussen - Vanlose, DK
Mikkel Jessing - Kobenhavn O, DK
Eman Mohamed Eldemenky - Wayne NJ, US
Bin Chen - East Windsor NJ, US
Yu Jiang - East Windsor NJ, US
Allen T. Hopper - Katonah NY, US
International Classification:

A61K 31/505
C07D 405/06
C07D 405/04
C07D 403/06
C07D 401/06
C07D 309/04
C07D 241/12
C07D 239/26
C07D 237/08
C07D 233/64
C07D 213/40
C07D 211/26
C07C 233/78
C07C 233/75
C07C 233/66
C07D 213/61
C07C 233/73
C07D 403/04
C07D 231/12
Abstract:

The present invention is directed to benzamide-containing compounds of formula Ior pharmaceutically acceptable salts thereof which inhibit the P2Xreceptor, and their use in the treatment of depression.

Cyclic Amines
view source
US Patent:

20190307766, Oct 10, 2019
Filed:

Oct 10, 2018
Appl. No.:

16/156648
Inventors:

- Kingston RI, US
Lars Kyhn Rasmussen - Vanløse, DK
Mikkel Jessing - Frederiksberg, DK
Eman Mohamed Eldemenky - Wayne NJ, US
Bin Chen - East Windsor NJ, US
Yu Jiang - East Windsor NJ, US
International Classification:

A61K 31/553
A61K 31/454
C07D 211/38
C07D 209/52
C07D 413/06
C07D 213/40
C07D 239/26
C07D 267/10
C07D 295/13
C07D 401/06
C07D 403/06
A61K 31/506
A61K 31/445
A61K 31/4453
A61K 31/4545
A61K 31/5375
A61K 31/5377
A61K 31/40
A61K 31/625
Abstract:

The present invention is directed to novel cyclic amines which inhibit the P2X7 receptor.

Substituted Tetrahydroisoquinoline Compounds Useful As Gpr120 Agonists
view source
US Patent:

20190161448, May 30, 2019
Filed:

May 19, 2017
Appl. No.:

16/096710
Inventors:

- Rahway NJ, US
Jason M. Cox - East Windsor NJ, US
John S. Debenham - Scotch Plains NJ, US
Scott Edmondson - Clark NJ, US
Eric J. Gilbert - Scotch Plains NJ, US
Yan Guo - Westfield NJ, US
Yu Jiang - East Windsor NJ, US
Hubert Josien - Jersey City NJ, US
Hyunjin M. Kim - Livingston NJ, US
Ping Lan - Plainsboro NJ, US
Shouwu Miao - Edison NJ, US
Christopher W. Plummer - Hoboken NJ, US
Murali Rajagopalan - Edison NJ, US
Unmesh Shah - Neshanic Station NJ, US
Zhongxiang Sun - Princeton NJ, US
Quang T. Truong - Morganville NJ, US
Feroze Ujjainwalla - Hoboken NJ, US
Francisco Velazquez - Clinton NJ, US
Srikanth Venkatraman - Edison NJ, US
Takao Suzuki - Shanghai, CN
Nengxue Wang - Shanghai, CN
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

C07D 217/04
C07D 401/12
C07D 401/04
C07D 401/06
C07D 417/04
C07D 417/14
C07D 417/12
C07D 413/04
A61P 3/10
A61P 3/06
A61P 3/04
A61P 29/00
Abstract:

The present invention relates to a compound represented by formula (I) and pharmaceutically acceptable salts thereof are disclosed as useful for treating or preventing diabetes, hyperlipidemia, obesity, NASH, inflammation related disorders, and related diseases and conditions. The compounds are useful as agonists of the G-protein coupled receptor GPR120. Pharmaceutical compositions and methods of treatment are also included.

Cyclic Amines
view source
US Patent:

20180177793, Jun 28, 2018
Filed:

Mar 19, 2018
Appl. No.:

15/848711
Inventors:

- Valby, DK
Lars Kyhn Rasmussen - Vanlose, DK
Mikkel Jessing - Frederiksberg, DK
Eman Mohamed Eldemenky - Wayne NJ, US
Bin Chen - East Windsor NJ, US
Yu Jiang - East Windsor NJ, US
International Classification:

A61K 31/553
A61K 31/4545
A61K 31/5375
A61K 31/454
A61K 31/40
A61K 31/5377
A61K 31/4453
A61K 31/506
A61K 31/445
Abstract:

The present invention is directed to novel cyclic amines which inhibit the P2X7 receptor.

Factor Xia Inhibitors
view source
US Patent:

20170210732, Jul 27, 2017
Filed:

Jul 23, 2015
Appl. No.:

15/329634
Inventors:

- Rahway NJ, US
Scott D. Edmondson - Clark NJ, US
Zhuyan Guo - Scotch Plains NJ, US
Anthony K. Ogawa - New Providence NJ, US
Rongze Kuang - Green Brook NJ, US
Heping Wu - Edison NJ, US
Amjad Ali - Freehold NJ, US
Yu Jiang - East Windsor NJ, US
Chunsing Li - Shanghai, CN
Tingting Yu - Shanghai, CN
Assignee:

Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:

C07D 409/14
C07D 401/06
C07D 401/14
C07D 417/14
C07D 413/14
Abstract:

The present invention provides a compound of Formula (I) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.

Benzamides-Containing Compounds And Their Use In The Treatment Of Epilepsy
view source
US Patent:

20170202836, Jul 20, 2017
Filed:

Apr 5, 2017
Appl. No.:

15/479972
Inventors:

- Valby, DK
Lars Kyhn Rasmussen - Vanløse, DK
Mikkel Jessing - København Ø, DK
Eman Mohamed Eldemenky - Wayne NJ, US
Bin Chen - East Windsor NJ, US
Yu Jiang - East Windsor NJ, US
Allen T. Hopper - Katonah NY, US
Assignee:

H. Lundbeck A/S - Valby
International Classification:

A61K 31/505
Abstract:

The present invention is directed to benzamide-containing compounds of formula Ior pharmaceutically acceptable salts thereof which inhibit the P2Xreceptor, and their use in the treatment of epilepsy.

Resumes

Yu Hui Jiang

view source

Yu Jiang

view source

Industry:

Education Management

Yu Jiang

view source

Skills:

Leadership
Microsoft Office
Microsoft Word
Powerpoint
Research
Microsoft Excel
Social Media
Marketing
Public Speaking
Customer Service

Yu Jiang

view source

Yu Jiang

view source

Yu Jiang Brooklyn, NY

view source

Work:

New York University

Sep 2009 to 2000
Research Assistant Mitsubishi Electrical Research Laboratories
Cambridge, MA
Jun 2013 to Aug 2013
Summer Research Intern Feedback Control Design

Mar 2010 to Mar 2012
Teaching Assistant for the lab session of EE3064 The Chinese University of Hong Kong
Hong Kong, Hong Kong Island
Nov 2007 to Dec 2007
Research Assistant

Education:

Polytechnic School of Engineering of New York University
Brooklyn, NY
2009 to 2014
PhD in Control and Optimization South China Unversity of Technology
Guangzhou, CN
2006 to 2009
M.Sc. in control theory and control engineering Sun Yat-sen (Zhongshan) University
Guangzhou, CN
2002 to 2006
B.Sc. in Mathematics

Skills:

MATLAB/Simulink, Mathematical Modeling, Algorithm Development, Optimization, Control Systems Design

Yu Jiang

view source

Location:

United States

Process Development Engineer At Lam Research

view source

Position:

Process Development Engineer at Lam Research

Location:

San Jose, California

Industry:

Semiconductors

Work:

Lam Research since Jun 2012
Process Development Engineer
Novellus Systems Jun 2011 - Jun 2012
Process Development Engineer
Lawrence Berkeley National Laboratory Nov 2009 - Jun 2011
Chemist Postdoc Fellow
University of California, Santa Cruz Sep 2004 - Aug 2009
Graduate Student Researcher
Novellus Systems Jun 2008 - Sep 2008
Process Intern

Education:

University of California, Santa Cruz 2004 - 2009
Ph.D, Condensed Matter Physics University of Science and Technology of China 1999 - 2004
B.S., Physics

Skills:

Fortran
Spectroscopy
Solid State Physics
X-ray
English
Mandarin
Linux
Shell Scripting
Chinese
LaTeX
Thin Films
Materials Science

Interests:

new science and technology, reading history books and scientific novels, surfing on the internet, watching films, enjoy good food

Honor & Awards:

Selected Publications “A Study of the local distortions of the Perovskite system La1-xSrxCoO3 (0 ≤ x ≤ 0.35) using the Extended X-ray Absorption Fine Structure technique”, Y. Jiang, F. Bridges, N. Sundaram, D. P. Belanger, I. E. Anderson, J. F. Mitchell, H. Zheng, Phys. Rev. B 80, 144423 (2009). “Local Structure of La1-xSrxCoO3 Determined from EXAFS and Neutron Pair Distribution Function Studies”, N. Sundaram, Y. Jiang, I. E. Anderson, D. P. Belanger, C. H. Booth, F. Bridges, J. F. Mitchell, Th. Proffen, and H. Zheng, Phys. Rev. Lett. 102, 026401 (2009). “Synthesis, Structural, and Optical Properties of Stable ZnS:Cu,Cl Nanocrystals”, C. Corrado, Y. Jiang, F. Oba, M. Kozina, F. Bridges, and J. Z. Zhang, J. Phys. Chem. A. 13, 3830 (2009). “Relationship between macroscopic physical properties and local distortions of low-doping La1-xCaxMnO3: An EXAFS study”, Y. Jiang, F. Bridges, L. Downward, and J. J. Neumeier, Phys. Rev. B 76, 224428 (2007).